Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 5, Number 3—June 1999


Application of Data Mining to Intensive Care Unit Microbiologic Data1

Stephen A. MoserComments to Author , Warren T. Jones, and Stephen E. Brossette
Author affiliations: The University of Alabama at Birmingham, Birmingham, Alabama, USA

Main Article

Table 3

Representative events identified and considered of potential interest

Left Denominator Right Numerator 1 2 3 4 5 6 7 Interpretation
 aureus Source
 TRACHASPc ==> R~Oxacillina, b R~Clindamycin R~Erythromycin 0/10 0/8 7/14 Increase in the incidence of oxacillin (ORSA), clindamycin and erythromycin resistance in all S. aureus isolated from tracheal aspirates.
NSNosod ==> R~Ceftazidime 3/88 11/70 Increase in incidence of ceftazidime resistance in all nosocomial isolates.
NP_GNRe ==> R~Piperacilli 0/17 6/14 Increase in the LocSICU incidence of piperacillin resistance in non-pseudo-monas gram-negative bacilli isolated from NSNoso.
NP_GNR ==> R~Piperacillin 1/12 0/14 4/11 4/8 Increase in the LocSICUf incidence of piperacillin resistance in non-pseudo-monas, nosocomial gram- negative bacilli from the SICU.
NSNoso LocNICUg ==> S. aureus 3/26 3/26 2/28 6/27 5/20 3/11 Increase in the incidence of nosocomial S. aureus in nosocomial isolates from the NICU.

aR, resistant.
bOxacillin, resistance implies resistance to amoxycillin/clavulanic acid, cephalothin, and cefazolin.
cSourceTRACHASP, tracheal aspirates.
dNSNoso, nosocomial (3 days from admission).
eNP_GNR, non-pseudomonas gram-negative rod.
fLocSICU, location, surgical intensive care unit (SICU).
gLocNICU, location, neonatal intensive care unit (NICU).

Main Article

1Presented in part at the International Conference on Emerging Infectious Diseases, March 8-11, 1998, Atlanta, Georgia.